Figure 1: PPAR-γ antagonism promotes ex vivo expansion of human cord blood HSPCs. Figure 3: PPAR-γ antagonism promotes ex vivo expansion of human cord blood HSCs by switching on FBP1-repressed ...
Chronic myeloid leukemia (CML) is a myeloproliferative disease that occurs because of a translocation between chromosomes 9 and 22 in hematopoietic stem cells. The switch results in a fusion of the ...
Researchers are exploring a novel quintuple agonist that targets five pathways, including GLP-1R, GIPR, and three PPARs. This innovative approach combines the benefits of incretin and PPAR pathways, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback